Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Hunter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Oncology (Williston Park, N.Y.)|June 11, 1991
Diagnosis and management of brain metastasis from gestational trophoblastic diseaseJ C Weed, V J Hunter
The Journal of Reproductive Medicine|March 1, 1993
Local anesthesia for cryosurgery on the cervixM J Sammarco, E M Hartenbach, V J Hunter
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1995
Tumor necrosis factor-alpha in the female reproductive tractP F Terranova, V J Hunter, K F Roby, et al.
Obstetrics and Gynecology|November 1, 1989
Short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgeryJ T Soper, D Larson, V J Hunter, et al.
Obstetrics and Gynecology|December 11, 1991
Epithelial ovarian tumors of low malignant potentialL S Massad, V J Hunter, C A Szpak, et al.
Obstetrics and Gynecology|February 1, 1990
Preoperative serum tumor-associated antigen levels in women with pelvic massesJ T Soper, V J Hunter, L Daly, et al.
American Journal of Obstetrics and Gynecology|November 1, 1995
Reduction of tumor necrosis factor-alpha bioactivity by a human ovarian epithelial cancer cell line in vitroM Sancho-Tello, J L Marcinkiewicz, W M Justice, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Gynecologic Oncology|September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)M L Rothenberg, P Y Liu, S Wilczynski, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncology (Williston Park, N.Y.)|June 11, 1991
Diagnosis and management of brain metastasis from gestational trophoblastic diseaseJ C Weed, V J Hunter
The Journal of Reproductive Medicine|March 1, 1993
Local anesthesia for cryosurgery on the cervixM J Sammarco, E M Hartenbach, V J Hunter
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1995
Tumor necrosis factor-alpha in the female reproductive tractP F Terranova, V J Hunter, K F Roby, et al.
Obstetrics and Gynecology|November 1, 1989
Short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgeryJ T Soper, D Larson, V J Hunter, et al.
Obstetrics and Gynecology|December 11, 1991
Epithelial ovarian tumors of low malignant potentialL S Massad, V J Hunter, C A Szpak, et al.
Obstetrics and Gynecology|February 1, 1990
Preoperative serum tumor-associated antigen levels in women with pelvic massesJ T Soper, V J Hunter, L Daly, et al.
American Journal of Obstetrics and Gynecology|November 1, 1995
Reduction of tumor necrosis factor-alpha bioactivity by a human ovarian epithelial cancer cell line in vitroM Sancho-Tello, J L Marcinkiewicz, W M Justice, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Gynecologic Oncology|September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)M L Rothenberg, P Y Liu, S Wilczynski, et al.
Pageof 1